Human HLA-B ELISA Kit, Lot 21AO-1202 [Cancer Immune Checkpoint Assay Kit]
CAT#: IOK-05-P1113
Product Type: ELISA Kit
Target: HLA-B
Short Description
The kit is designed for in vitro quantitative measurement of Human HLA-B in Cell Culture Supernatant, Plasma, Serum.
Description
Human Leucocyte Antigen B27 ELISA Kit is an ELISA kit against Human Leucocyte Antigen B27.
Applications
ELISA
Application Notes
The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Comment
The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Target
HLA-B
Reactivity
Human
Detection Method
Colorimetric
Analytical Method
Quantitative
Sample Type
Cell Culture Supernatant, Plasma, Serum
Sensitivity
22 pg/mL
Plate
Pre-coated
Storage
4 °C/-20 °C
Storage Comment
Store at 2°C to 8°C upon receipt.
Note
Store at 2°C to 8°C upon receipt.
Restrictions
For Research Use only
Alternative Name
Major Histocompatibility Complex Class I B (MHCB)
Synonyms
AS; HLAB; SPDA1; mhc1b; major histocompatibility complex; class I; B; major histocompatibility complex nonclassical class Ib L homeolog; HLA-B; BOLA-B; MAMU-B18; DKFZP469N1225; mhc1b.L
Gene ID
3008
UniProt
P03989
Pathways
Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response